Antileukemic action of novel diamine Pt(II) halogenido complexes: Comparison of the representative novel Pt(II) with corresponding Pt(IV) complex
- 14 February 2017
- journal article
- research article
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 90 (2) , 262-271
Abstract
This study presents the synthesis, characterization, and antitumor action of five new Pt(II) halogenido, chlorido, and iodido complexes with edda type of ligands. (S,S)‐Ethylenediamine‐N,N′‐di‐2‐(3‐cyclohexyl)propanoic acid dihydrochloride and its methyl, ethyl, and n‐propyl esters were prepared according to the previously reported procedure. All investigated complexes were characterized by IR, ESI‐MS (1H, 13C, and HMBC) NMR spectroscopy, and elemental analysis. Their cytotoxic action was investigated in four human tumor cell lines: promyelocytic (HL‐60) and lymphocytic (REH) leukemia, glioma (U251), and lung carcinoma (H460). Cell viability was assessed by acid phosphatase and LDH assay, while oxidative stress and cell death parameters were analyzed by flow cytometry. The results showed that novel Pt(II) complexes exhibited antitumor action superior to precursor ligands, with iodido complexes being more efficient than corresponding chlorido complexes. Human promyelocytic cell line (HL‐60) was the most sensitive to antitumor action of all investigated substances and was used for investigation of the underlying mode of antileukemic action. The investigated Pt(II) complexes showed more potent antileukemic action than corresponding Pt(IV) complex, through induction of oxidative stress and apoptosis, evidenced by caspase (8, 9, and 3) activation and phosphatidylserine externalization.Keywords
Funding Information
- Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja (172035, III 41025)
This publication has 30 references indexed in Scilit:
- The second generation of iodido complexes: trans-[PtI2(amine)(amine′)] bearing different aliphatic aminesJournal of Inorganic Biochemistry, 2013
- Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012Cell Death & Differentiation, 2011
- Synthesis and in vitro Anticancer Activity of Octahedral Platinum(IV) Complexes with Cyclohexyl‐Functionalized Ethylenediamine‐N,N′‐Diacetate‐Type LigandsChemMedChem, 2010
- AMPK‐mediated autophagy inhibits apoptosis in cisplatin‐treated tumour cellsJournal of Cellular and Molecular Medicine, 2009
- The resurgence of platinum-based cancer chemotherapyNature Reviews Cancer, 2007
- Apoptosis: A Review of Programmed Cell DeathToxicologic Pathology, 2007
- A glucose derivative as natural alternative to the cyclohexane‐1,2‐diamine ligand in the anticancer drug oxaliplatin?ChemMedChem, 2007
- Chemotherapy and the war on cancerNature Reviews Cancer, 2005
- Cytotoxicity of asymmetric platinum complexes against L-1210 cells. Effect of bulky substituents.Chemical and Pharmaceutical Bulletin, 1990
- Studies on the antitumor activity of group VIII transition metal complexes. Part I. Platinum (II) complexesBioinorganic Chemistry, 1973